Better Therapeutics Inc. is a digital therapeutics company focused on revolutionizing healthcare through innovative, software-based interventions for chronic diseases. Headquartered in Boston, Massachusetts, the company leverages cutting-edge technology to deliver evidence-based interventions that empower patients to manage their health conditions and improve their overall well-being.
The core mission of Better Therapeutics is to address chronic diseases like diabetes and other metabolic conditions by providing clinically validated, prescription-grade digital therapeutics. These interventions are designed to complement traditional medical treatments and empower patients to make lasting lifestyle changes that can lead to improved health outcomes.
One of the company's flagship products is BT-001, a digital therapeutic for diabetes management. This app-based platform delivers personalized interventions, including cognitive behavioral therapy and educational content, to help patients manage their condition more effectively. The platform is built on rigorous clinical research and is designed to engage users and drive behavior change.
Better Therapeutics operates at the intersection of healthcare and technology, utilizing data analytics, machine learning, and behavioral science to create personalized treatment plans. By continuously analyzing user data, the company adapts and refines its interventions to better suit individual patient needs and preferences.
The company's collaboration with healthcare providers, payers, and pharmaceutical companies underscores its commitment to integrating digital therapeutics into the broader healthcare ecosystem. This approach facilitates better patient outcomes, reduces healthcare costs, and supports healthcare professionals in delivering effective care.